Glomerulonephritis Clinical Trials Glomerulonephritis RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits
Condition:   Proliferative Glomerulonephritis With Monoclonal IgG Deposits Intervention:   Drug: Daratumumab Sponsor:   Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 16, 2022 Category: Research Source Type: clinical trials